Table 8.

Characteristics and outcome of feline patients treated with pump inhibitors and chemotherapy

PATIENT	AGE	TUMOR	PREV. TREATMENT	THERAPY	OUTCOME (MONTHS)
DSH	10	BREAST CARCINOMA	SURGERY MITOXANTRONE PD	MITOXANTRONE	PR 4
DSH	12	ORAL SCC	MITOXANTRONE PD	MITOXANTRONE	SD 2
DSH	10	ORAL SCC	SURGERY MITOXANTRONE PD	MITOXANTRONE	CR 5+
DSH	12	ORAL SCC	BIOPSY MITOXANTRONE PD	MITOXANTRONE	SD 6
DSH	12	LSA	MOPP × 3 months	MOPP	CR 6+
DSH	8	NASAL LSA	MOPP PD	MOPP	PR 3+
DSH	7	FSA	SURGERY, ECT × 2, CARBOPLATIN × 2 MITOXANTRONE × 2	MITOXANTRONE	PD

Abbreviations: DSH: domestic short hair; ECT: electrochemotherapy; FSA: fibrosarcoma; LSA: lymphosarcoma; MOPP: mechlorethamine, oncovin (vincristine), prednisone, procarbazine; SCC: squamous cell carcinoma. +: still alive.

Drugs schedule: doxorubicin 30 mg/m² every 21 days (pending hematological, cardiac and renal evaluation) up to 6 doses, carboplatin 210 mg/m² every 21 days, mitoxantrone 6 mg/m² every 21 days. For MOPP protocol see table 4 and 5.